Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7757005 | 0.84 | CYP4F2 (0.57) | PRSS1PRSS2PRSS3CYP4F2CYP4A11 | |
| SCHEMBL1363307 | 0.83 | BCL2 (0.43) | PRSS1PRSS2PRSS3CYP4F2CYP4A11 | |
| SCHEMBL608583 | 0.83 | LOXL2 (0.37) | PRSS1PRSS2PRSS3TSHRCYP4F2 | |
| SCHEMBL16952890 | 0.83 | PRSS1 (0.59) | PRSS1PRSS2PRSS3ENPP2TSHR | |
| SCHEMBL27702621 | 0.82 | LOXL2 (0.58) | PRSS1PRSS2PRSS3ENPP2SMN1; SMN2 | |
| SCHEMBL20919035 | 0.82 | ALDH1A1 (0.39) | PRSS1PRSS2PRSS3TSHRCYP4F2 | |
| SCHEMBL25955246 | 0.82 | FOLH1 (0.58) | PRSS1PRSS2PRSS3CYP4F2CYP4A11 | |
| SCHEMBL11600508 | 0.82 | TSHR (0.39) | PRSS1PRSS2PRSS3TSHRCYP4F2 | |
| SCHEMBL14452916 | 0.80 | PRSS1 (0.52) | PRSS1PRSS2PRSS3ENPP2TSHR | |
| SCHEMBL1361055 | 0.80 | KAT6A (0.44) | CYP4F2CYP4A11CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024080062-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | テクノＵＭＧ株式会社 | 2024-04-18 | — | — | WO | disclosed |
| US-11866573-B2 | Thermoplastic resin composition and molded article | TECHNO-UMG CO., LTD. (JP) | 2024-01-09 | — | — | US | disclosed |
| EP-4023726-A1 | COATING RESIN COMPOSITION, AND MOLDED PRODUCT | Techno-UMG Co., Ltd. (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-110741043-B | Thermoplastic resin composition and molded article | 大科能宇菱通株式会社 | 2022-04-15 | — | — | CN | disclosed |
| CN-113993955-A | Resin composition for coating and molded article | 大科能宇菱通株式会社 | 2022-01-28 | — | — | CN | disclosed |
| US-11046800-B2 | Resin component disposed in route of beam emitted by radar device, radome, and radar device | TECHNO-UMG CO., LTD. (JP) | 2021-06-29 | — | — | US | disclosed |
| US-20210087378-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | TECHNO-UMG CO., LTD. (JP) | 2021-03-25 | — | — | US | disclosed |
| WO-2021039741-A1 | COATING RESIN COMPOSITION, AND MOLDED PRODUCT | テクノＵＭＧ株式会社 | 2021-03-04 | — | — | WO | disclosed |
| CN-108603005-B | Resin member disposed on path of beam emitted from radar device, radome, and radar device | 大科能宇菱通株式会社 | 2020-11-03 | — | — | CN | disclosed |
| US-20200262958-A1 | RESIN COMPONENT DISPOSED IN ROUTE OF BEAM EMITTED BY RADAR DEVICE, RADOME, AND RADAR DEVICE | TECHNO-UMG CO., LTD. (JP) | 2020-08-20 | — | — | US | disclosed |
| WO-2005026331-A2 | METHOD OF PREPARATION OF PHARMACEUTICALLY GRADE PLASMID DNA | CENTELION (FR) | 2005-03-24 | — | — | WO | disclosed |
| EP-0964057-B1 | Method for separating nucleic acids by means of liquid chromatography | TOSOH CORP (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-20040034155-A1 | Acenaphthylene derivative, polymer, and antireflection film-forming composition | JSR CORPORATION (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-1386904-A1 | Acenaphthylene derivative, polymer, and antireflection film-forming composition | JSR Corporation (JP) | 2004-02-04 | — | — | EP | disclosed |
| US-6441160-B2 | HYDROPHOBIC INTERACTION CHROMATOGRAPHY USING PACKING MATERIAL WITH FUNCTIONAL GROUP INTRODUCED TO ADSORB NUCLEIC ACIDS THAT EXHIBIT CERTAIN HYDROPHOBICITY | TOSOH CORPORATION (JP) | 2002-08-27 | — | — | US | disclosed |
| US-20010007026-A1 | METHOD OF SEPARATING NUCLEIC ACIDS BY MEANS OF LIQUID CHROMATOGRAPHY | TOSOH CORPORATION (JP) | 2001-07-05 | — | — | US | disclosed |
| EP-0964057-A1 | Method for separating nucleic acids by means of liquid chromatography | TOSOH CORPORATION (JP) | 1999-12-15 | — | — | EP | disclosed |
| US-5234946-A | Anticholesterol, antilipemic | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-10 | — | — | US | disclosed |
| EP-0318860-B1 | SUBSTITUTED ALKYLAMINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0318860-A2 | Substituted alkylamine derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010007026-A1 | METHOD OF SEPARATING NUCLEIC ACIDS BY MEANS OF LIQUID CHROMATOGRAPHY | DNA2, HNRNPH3, POLRMT | PRSS1 1539/4885PRSS2 486/4885PRSS3 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.